These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7525881)

  • 21. Membrane-induced secondary structures of neuropeptides: a comparison of the solution conformations adopted by agonists and antagonists of the mammalian tachykinin NK1 receptor.
    Whitehead TL; McNair SD; Hadden CE; Young JK; Hicks RP
    J Med Chem; 1998 Apr; 41(9):1497-506. PubMed ID: 9554882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide-based tachykinin NK2 receptor antagonists.
    Quartara L; Rovero P; Maggi CA
    Med Res Rev; 1995 Mar; 15(2):139-55. PubMed ID: 7537837
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of tachykinins on ascending and descending reflex pathway in rat small intestine.
    Hahn A; Storr M; Allescher HD
    Acta Pharmacol Sin; 2002 Apr; 23(4):289-95. PubMed ID: 11931700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors.
    Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Nakazato P; Debas HT; Geppetti P
    Eur J Pharmacol; 1993 Aug; 239(1-3):103-9. PubMed ID: 8223885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
    Turcatti G; Vogel H; Chollet A
    Biochemistry; 1995 Mar; 34(12):3972-80. PubMed ID: 7696262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore and receptor models for neurokinin receptors.
    Poulsen A; Bjørnholm B; Gundertofte K; Pogozheva ID; Liljefors T
    J Comput Aided Mol Des; 2003 Nov; 17(11):765-83. PubMed ID: 15072436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle.
    Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L
    Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
    Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
    Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tachykinin-mediated respiratory effects in conscious guinea pigs: modulation by NK1 and NK2 receptor antagonists.
    Kudlacz EM; Logan DE; Shatzer SA; Farrell AM; Baugh LE
    Eur J Pharmacol; 1993 Sep; 241(1):17-25. PubMed ID: 7693493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in neurokinin receptor antagonists.
    Gao Z; Peet NP
    Curr Med Chem; 1999 May; 6(5):375-88. PubMed ID: 10101218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
    Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut.
    Wang Y; Badgery-Parker T; Lovas S; Chartrel N; Vaudry H; Burcher E; Conlon JM
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):827-32. PubMed ID: 1332683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent and highly selective neurokinin antagonists.
    Ward P; Ewan GB; Jordan CC; Ireland SJ; Hagan RM; Brown JR
    J Med Chem; 1990 Jul; 33(7):1848-51. PubMed ID: 1694545
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
    Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
    Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilisation of a bent conformation in a neurokinin A analogue by an a,a-dialkyl amino acid.
    Hussain R; Guthrie DJ; Irvine GB; Stevenson PJ; Allen JM
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):269S. PubMed ID: 8135925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.